Sequential re-rating: management describes the same offering landing bigger the second and third time around
The model's full reasoning — Q1 2016 call → NO我们根据提供的财报电话会议记录,判断管理层是否描述了“同类业务连续接洽的规模逐步扩大”的现象。即,公司现在获得的交易、订单、合同、项目、客户、站点或项目,是否比不久前的同类业务更大、更广或更长。 在记录中,管理层提到了多个新合同和扩展,例如: - IAG(英国航空、伊比利亚航空、爱尔兰航空)决定安装2Ku,涉及130多架飞机。 - 与Shareco合作,在中国安装2Ku于50架飞机。 - 与Air Canada扩展关系,安装2Ku于其整个宽体国际机队。 - Delta增加承诺至超过600架2Ku飞机。 - 2Ku获奖飞机总数超过1000架。 这些是否表明“单位规模”在逐步扩大?管理层是否明确对比了现在与过去的规模?例如,是否说“现在的合同比过去更大”?在记录中,管理层提到“2Ku awarded aircraft over the 1000 mark”,并说“we are off to an amazing start”,但并没有明确说“每个新合同的规模比过去大”。他们提到了多个新合同,但都是不同航空公司,没有直接对比同一类业务的单位规模变化。 另外,管理层提到“we secured large capacity commitments with Intelsat and SES”,但这是卫星容量,不是直接业务规模。 关于“比较”方面,管理层没有明确说“现在的合同比过去大”,而是说“2Ku awards now exceed 1000 aircraft”,这可能是数量增加,但单位规模(每架飞机)是否变大?没有明确。 此外,管理层提到“we are making great progress on the increasing volume of STCs”,但这是认证数量,不是合同规模。 在回答中,管理层没有明确表达“单位规模在升级”的现象。他们只是报告了多个新合同和扩展,但未对比过去。例如,他们提到“Delta increased their commitment to more than 600 2Ku aircraft”,但这是增加数量,不是单位规模。 因此,根据要求,答案应为NO,因为管理层没有明确描述“同类业务连续接洽的规模逐步扩大”的现象。他们只是报告了更多合同,但未对比单位大小。 所以,回答NO。
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ASO | Academy Sports and Outdoors, Inc. | Q1 2024 | 2024-06-11 | C+ |
| AKYA | Akoya Biosciences, Inc. | Q2 2023 | 2023-08-07 | C+ |
| SPT | Sprout Social, Inc. | Q2 2023 | 2023-08-04 | B+ |
| SGRY | Surgery Partners, Inc. | Q2 2022 | 2022-08-02 | B+ |
| CYBR | CyberArk Software Ltd. | Q3 2021 | 2021-11-04 | B+ |
| ASAN | Asana, Inc. | Q2 2022 | 2021-09-01 | B+ |
| OWL | Blue Owl Capital Inc. | Q2 2021 | 2021-08-10 | B+ |
AKYA · Q2 2023 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES The transcript shows management describing a clear pattern of escalating project sizes in the translational/clinical space. Brian notes a migration from exploratory studies (reasonable size) to larger retrospective studies and even larger retrospective-prospective ongoing clinical studies, with projects moving "further and further downstream.
ASAN · Q2 2022 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES Management describes exactly this pattern. Dustin notes the company is “closing larger deals and expanding seats across departments and geographies quickly in large organizations,” and that the growth in the >$50k cohort “reflected an acceleration in our largest enterprise customers.
SGRY · Q2 2022 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES The transcript shows management describing exactly this pattern for physician recruiting cohorts. Wayne notes that the 2022 cohorts are “no exception to this trend, bringing more cases with a higher overall net revenue per case than our 2021 cohorts did in the same period last year.